Abstract: Disclosed are a compound represented by Formula (1), or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, tautomer, enantiomer, or pharmaceutically acceptable diastereomer thereof, a method of preparing the same, and a pharmaceutical composition, which have effects for treatment or prevention of metabolic syndromes, comprising the same: wherein R1 to R6, X1 to X4, and n are the same as defined in Claim 1.
Type:
Application
Filed:
December 30, 2014
Publication date:
December 29, 2016
Applicant:
KT&G LIFE SCIENCES CORPORATION
Inventors:
Whee Seong LEE, Mi Jung LEE, Bo Jung KIM, Tae Cheul ROH, Seung Hoon LEE, Kyu Dae LEE, You-Hui LEE, Tae Hwan KWAK
Abstract: Disclosed are a compound represented by Formula (1), or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, tautomer, enantiomer, or pharmaceutically acceptable diastereomer thereof, a method of preparing the same, and a pharmaceutical composition, which have effects for treatment or prevention of metabolic syndromes, comprising the same: wherein R1 to R3, and X1 to X6 are the same as defined in Claim 1.
Type:
Application
Filed:
December 30, 2014
Publication date:
December 29, 2016
Applicant:
KT&G LIFE SCIENCES CORPORATION
Inventors:
Whee Seong LEE, Mi Jung LEE, Bo Jung KIM, Tae Cheul ROH, Seung Hoon LEE, Kyu Dae LEE, You-Hui LEE, Tae Hwan KWAK